Key facts
- This page summarizes Gary G. Gemignani's Form 4 filing for Bluejay Diagnostics, Inc. (BJDX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Feb 2023, 15:29.
Gary G. Gemignani - 01 Feb 2023 Form 4 Insider Report for Bluejay Diagnostics, Inc. (BJDX)
- Reporting relationship
- Director
- Issuer ticker
- BJDX
- Reported as of
- 01 Feb 2023
- Net transaction value
- +$12,100
- SEC form
- 4
- Accepted by SEC
- 16 Feb 2023, 15:29:37 UTC
- Prior SEC filing
- 23 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gary Gemignani
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gary G. Gemignani filed Form 4 for Bluejay Diagnostics, Inc. (BJDX) on 16 Feb 2023.
Change
- Previous filing in this sequence was filed on 23 Mar 2022.
- Current net transaction value: +$12,100.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BJDX
transaction
Common Stock
Award
- Transaction value
- $12,100
- Shares
- +27,500
- Change %
- Price
- $0.4400
- Shares after
- 27,500
- Date
- 01 Feb 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
These shares of restricted stock vest at 100% on the first anniversary of the grant date.